Vanguard Personalized Indexing Management’s Adaptive Biotechnologies ADPT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$767K	Buy	35,739 +285	+0.8%	+$4.37K	0.01%	1143
2026 Q1	$492K	Buy	35,454 +2,982	+9%	+$47.5K	﹤0.01%	1324
2025 Q4	$527K	Sell	32,472 -54	-0.2%	-$881	0.01%	1225
2025 Q3	$487K	Buy	32,526 +488	+2%	+$5.95K	0.01%	1256
2025 Q2	$373K	Buy	32,038 +2,880	+10%	+$26.2K	﹤0.01%	1340
2025 Q1	$217K	Buy	29,158 +2,588	+10%	+$19.9K	﹤0.01%	1486
2024 Q4	$159K	Buy	26,570 +2,741	+12%	+$15.1K	﹤0.01%	1559
2024 Q3	$122K	Buy	23,829 +1,504	+7%	+$6.55K	﹤0.01%	1588
2024 Q2	$80.8K	Buy	+22,325	New	+$70.9K	﹤0.01%	1551

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Personalized Indexing Management's ADPT Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Adaptive Biotechnologies (ADPT) stake by 0.8% in Q2 2026, buying an estimated $4.37K and bringing the position to 35,739 shares worth $767K. The position accounts for 0.01% of the portfolio, ranked #1143.

Vanguard Personalized Indexing Management first reported a position in ADPT in Q2 2024 and has held it in 9 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Vanguard Personalized Indexing Management held 35,739 shares of Adaptive Biotechnologies worth $767K as of Q2 2026.
Vanguard Personalized Indexing Management bought 285 Adaptive Biotechnologies shares in Q2 2026, an estimated $4.37K.
Adaptive Biotechnologies made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1143 holding.
Vanguard Personalized Indexing Management first reported a position in Adaptive Biotechnologies in Q2 2024 and has held it in 9 quarters since.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.